These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26878362)

  • 21. Duloxetine ameliorates the impairment of diffuse noxious inhibitory control in rat models of peripheral neuropathic pain and knee osteoarthritis pain.
    Yoneda S; Kasai E; Matsuo M; Tamano R; Sakurai Y; Asaki T; Fujita M
    Neurosci Lett; 2020 Jun; 729():134990. PubMed ID: 32315711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of pregabalin - codeine combination on partial sciatic nerve ligation - induced peripheral mononeuropathy in rats.
    Popa G; Mititelu Tartau L; Stoleriu I; Lupusoru RV; Lupusoru CE; Ochiuz L
    J Physiol Pharmacol; 2016 Jun; 67(3):465-9. PubMed ID: 27512007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
    Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
    Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Rheumatol Int; 2016 May; 36(5):663-72. PubMed ID: 27000046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of thiamin on the efficacy of pregabalin in rats with spinal nerve ligation (SNL)-induced neuropathic pain.
    Liu L; Ma SH; Xia LJ
    Neurol Res; 2016 Aug; 38(8):717-24. PubMed ID: 27334563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-10 levels in rat models of nerve damage and neuropathic pain.
    Khan J; Ramadan K; Korczeniewska O; Anwer MM; Benoliel R; Eliav E
    Neurosci Lett; 2015 Apr; 592():99-106. PubMed ID: 25757362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study on comparative efficacy and cost effectiveness of Pregabalin and Duloxetine used in diabetic neuropathic pain.
    Roy MK; Kuriakose AS; Varma SK; Jacob LA; Beegum NJ
    Diabetes Metab Syndr; 2017; 11(1):31-35. PubMed ID: 27484440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A back translation of pregabalin and carbamazepine against evoked and non-evoked endpoints in the rat spared nerve injury model of neuropathic pain.
    Lau W; Dykstra C; Thevarkunnel S; Silenieks LB; de Lannoy IA; Lee DK; Higgins GA
    Neuropharmacology; 2013 Oct; 73():204-15. PubMed ID: 23747575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy.
    Kuo A; Corradini L; Nicholson JR; Smith MT
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain.
    Imam MZ; Kuo A; Nicholson JR; Corradini L; Smith MT
    Pharmacol Rep; 2020 Oct; 72(5):1418-1425. PubMed ID: 32715433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug combinations in diabetic neuropathic pain: an experimental validation.
    Tripathi CD; Mehta AK; Yadav AM
    J Basic Clin Physiol Pharmacol; 2016 Nov; 27(6):617-624. PubMed ID: 27331307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A model of neuropathic pain induced by sorafenib in the rat: Effect of dimiracetam.
    Di Cesare Mannelli L; Maresca M; Farina C; Scherz MW; Ghelardini C
    Neurotoxicology; 2015 Sep; 50():101-7. PubMed ID: 26254739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
    Carlos F; Espejel L; Novick D; López R; Flores D
    Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-[4-(3-Trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one and pregabalin attenuate tactile allodynia in the mouse model of chronic constriction injury.
    Sałat K; Witalis J; Zadrożna M; Sołtys Z; Nowak B; Filipek B; Więckowski K; Malawska B
    Toxicol Mech Methods; 2015; 25(7):514-23. PubMed ID: 25996035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of Pregabalin Compared to Duloxetine in Diabetic Peripheral Neuropathic Pain: An Observational Study.
    Jha S; Sahani OP; Siddiqui S; Verma MK; Mazumder A; Waghdhare S
    J Assoc Physicians India; 2019 Nov; 67(11):32-36. PubMed ID: 31793266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Efficacy and Safety of Pregabalin and Duloxetine in Taxane-Induced Sensory Neuropathy: A Randomized Controlled Trial.
    Salehifar E; Janbabaei G; Hendouei N; Alipour A; Tabrizi N; Avan R
    Clin Drug Investig; 2020 Mar; 40(3):249-257. PubMed ID: 31925721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analgesic treatment with pregabalin does not prevent persistent pain after peripheral nerve injury in the rat.
    Yang F; Whang J; Derry WT; Vardeh D; Scholz J
    Pain; 2014 Feb; 155(2):356-366. PubMed ID: 24176928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel use of perineural pregabalin infusion for analgesia in a rat neuropathic pain model.
    Buys MJ; Alphonso C
    Anesth Analg; 2014 Aug; 119(2):481-488. PubMed ID: 24914629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming growth factor-beta in the red nucleus plays antinociceptive effect under physiological and pathological pain conditions.
    Wang J; Yu J; Ding CP; Han SP; Zeng XY; Wang JY
    Neuroscience; 2015 Apr; 291():37-45. PubMed ID: 25662509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial.
    Selvarajah D; Petrie J; White D; Julious S; Bortolami O; Cooper C; Bradburn M; Loban A; Bowler H; Swaby L; Sutherland K; Tesfaye S;
    Trials; 2018 Oct; 19(1):578. PubMed ID: 30348206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.